Increased CD16 expression on NK cells is indicative of antibody-dependent cell-mediated cytotoxicity in chronic-active antibody-mediated rejection.
Adult
Aged
Antibody-Dependent Cell Cytotoxicity
B-Lymphocytes
/ immunology
Case-Control Studies
Chronic Disease
Female
Flow Cytometry
Graft Rejection
/ immunology
HLA Antigens
/ immunology
Humans
Isoantibodies
/ metabolism
Kidney Transplantation
Killer Cells, Natural
/ immunology
Lymphocyte Activation
Male
Middle Aged
Receptors, Antigen, T-Cell, gamma-delta
/ metabolism
Receptors, IgG
/ metabolism
T-Lymphocytes
/ immunology
Biomarkers
Chronic active antibody mediated rejection
Circulating immune cells
Kidney transplantation
Journal
Transplant immunology
ISSN: 1878-5492
Titre abrégé: Transpl Immunol
Pays: Netherlands
ID NLM: 9309923
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
27
09
2018
revised:
11
02
2019
accepted:
12
02
2019
pubmed:
23
2
2019
medline:
18
12
2019
entrez:
23
2
2019
Statut:
ppublish
Résumé
Chronic-active antibody mediated rejection (c-aABMR) contributes significantly to late renal allograft failure. The antibodies directed against donor-derived antigens, e.g. anti-HLA antibodies, cause inflammation at the level of the microvascular endothelium. This is characterized by signs of local activation of the complement system and accumulation of immune cells within the capillaries. Non-invasive biomarkers of c-aABMR are currently not available but could be valuable for early detection. We therefore analyzed the activation profiles of circulating T and B cells, NK cells and monocytes in the peripheral blood of 25 kidney transplant recipients with c-aABMR and compared them to 25 matched recipients to evaluate whether they could serve as a potential biomarker. No significant differences were found in the total percentage and distribution of NK cells, B cells and T cells between the c-aABMRpos and c-aABMRneg cases. There was however a higher percentage of monocytes present in c-aABMRpos cases (p < .05). Additionally, differences were found in activation status of circulating monocytes, NK cells and γδ T cells, mainly concerning the activation marker CD16. Although statistically significant, these differences were not sufficient for use as a biomarker of c-aABMR.
Identifiants
pubmed: 30794946
pii: S0966-3274(18)30134-5
doi: 10.1016/j.trim.2019.02.005
pii:
doi:
Substances chimiques
HLA Antigens
0
Isoantibodies
0
Receptors, Antigen, T-Cell, gamma-delta
0
Receptors, IgG
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
52-58Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.